Linde A. Miles

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

Zhan Yao, Rona Yaeger, Vanessa Rodrik-Outmezguine et al. · Nature · 2017 · 540 citations

Oncology, Activated Ras, Class 3 +12

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

Eric E. Gardner, Benjamin H. Lok, Valentina E. Schneeberger et al. · Cancer Cell · 2017 · 513 citations · Full text

Oncology, Chemosensitive Relapse, Medicine +9

Single-cell mutation analysis of clonal evolution in myeloid malignancies

Linde A. Miles, Robert L. Bowman, Tiffany R. Merlinsky et al. · Nature · 2020 · 500 citations · Full text

Hematological Malignancy, Tumor Heterogeneity, Hematology +7

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Kipp Weiskopf, Nadine S. Jahchan, Peter J. Schnorr et al. · Journal of Clinical Investigation · 2016 · 421 citations · Full text

Immune Evasion, Cd47-blocking Immunotherapies, Cancer Immunosurveillance +14

Substrate positioning controls the partition between halogenation and hydroxylation in the aliphatic halogenase, SyrB2

Megan L. Matthews, Christopher S. Neumann, Linde A. Miles et al. · Proceedings of the National Academy of Sciences · 2009 · 257 citations · Full text